Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.20 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc/ and changes regularly. See the Directory of published versions
Generated Narrative: SubstanceDefinition
Resource SubstanceDefinition "21b6b724-507e-4cf4-a462-93334b98d166"
Profile: Substance General Information
identifier: levoThyroxine
classification: Chemical (Dummy EMA Codesystem#1)
manufacturer: urn:uuid:e875ef93-a730-4c44-bead-53663ae7f501
supplier: urn:uuid:e165f057-5eed-4e64-8328-4438fc88fb1b
Amount |
798.85 u (Details: http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy code C41127 = 'u') |
structure
technique: NMR Spectroscopy ()
representation
type: InChI File (small molecule) (Dummy NCIT Codesystem#C54683)
representation: YDTFRJLNMPSCFM-YDALLXLXSA-M
representation
type: SMILES (Dummy NCIT Codesystem#C54684)
representation: [Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O
representation
representation
Code |
054I36CPMN (gsrs.ncats.nih.gov#054I36CPMN) |
name
name: LEVOTHYROXINE SODIUM ANHYDROUS
type: GSRS Preferred Term (Dummy NCIT Codesystem#C203355)
preferred: true
name
name: sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate
type: IUPAC Name (Dummy NCIT Codesystem#C203356)
name
name: 55-03-8
type: CAS Number (Dummy NCIT Codesystem#C54682)
SubstanceDefinition[x] | Type |
urn:uuid:832f22b4-6f0c-41f8-9b7d-f26f55e9973c | Polymorph () |